伊佩拉托林通过调节Suv39h1/Fabps/Cept1信号通路来改善与代谢功能障碍相关的脂肪肝疾病
Yi Sun1,2, Changyuan Wang1, Yang Wang1
1Academy of Integrative Medicine, Dalian Medical University, Dalian, China.
British journal of pharmacology
|November 11, 2025
概括
伊佩拉托林通过向Suv39h1,这是脂质代谢的关键调节者,从而延迟代谢功能障碍相关的脂肪肝疾病 (MAFLD). 这种天然化合物调节Suv39h1/Fabps/Cept1通路,为MAFLD提供了潜在的治疗策略.
科学领域:
- 肝病学和胃肠道学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是肝纤维化和癌症的重要原因.
- Imperatorin 显示出可能导致肝损伤的可能性,但其 MAFLD 机制尚不清楚.
研究的目的:
- 研究 Imperatorin 对 MAFLD 的影响.
- 阐明MAFLD中imperatorin的分子机制.
主要方法:
- 高脂肪饮食诱导的MAFLD小鼠模型和用棕酸治疗的肝细胞.
- 分子对接,细胞热转移检测和SPR以确定imperatorin的目标为Suv39h1.1.
- 通过RNA测序,CHIP,DNA下拉和双化酶记者测试来分析Suv39h1/Fabps/Cept1通路.
主要成果:
- 伊佩拉托林通过改善脂质代谢,炎症和胰岛素抵抗来改善MAFLD.
- Suv39h1是 Imperatorin 的直接目标,调解其治疗效果.
- Suv39h1通过Fabps促进体的基因组甲基化调节脂质代谢,影响Fabps和Cept1的表达.
结论:
- 通过调节Suv39h1/Fabps/Cept1信号通路,Imperatorin对MAFLD产生治疗作用.
- 向Suv39h1为MAFLD治疗提供了一个新的治疗途径.
相关概念视频
Overview of Fatty Acid Metabolism
36.3K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
36.3K
Ultrasound II: Endoscopic Ultrasound and FibroScan
519
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
519
Lipid Catabolism
833
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
833
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163


